ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1,4,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
3,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
4,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
6,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
7,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
7,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
7,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
9,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
11,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
12,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
12,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
13,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
13,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
13,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
13,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
13,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
14,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
14,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
15,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
16,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
17,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
18,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
19,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
20,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
20,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
20,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
21,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
21,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
22,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
22,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
23,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
24,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
24,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
25,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
26,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
27,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
27,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
29,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
30,1,Cerebral artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
30,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
30,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
31,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
32,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
33,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
35,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
36,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
37,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
37,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
39,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
39,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
39,3,Paresis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
40,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
41,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
42,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
43,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
44,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
46,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
47,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
48,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
49,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
51,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
52,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
53,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
54,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
54,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
54,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
55,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
55,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
55,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
56,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
57,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
58,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
59,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
60,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
61,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
62,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
63,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
63,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
64,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
65,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
66,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
67,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
69,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
70,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
71,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
72,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
72,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
73,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
74,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
75,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
76,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
77,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
78,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
79,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
81,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
81,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
82,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
83,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
83,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
84,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
84,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
85,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
86,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
87,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
88,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
89,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
90,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
91,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
92,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
93,1,Brain stem ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
93,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
94,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
95,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
95,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
96,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
97,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
98,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
99,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
100,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,Y
100,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
101,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
101,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
101,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
102,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
103,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
104,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,Y
104,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
105,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
106,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
107,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
107,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
108,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
109,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
110,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
111,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
112,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
113,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
114,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
115,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
116,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
117,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
118,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
120,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
120,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
121,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
121,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
121,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
122,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
123,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
124,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
125,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
126,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
126,2,Tonsillar disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
127,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
127,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
127,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
128,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
129,1,Sterile pyuria,Genitourinary tract infections and inflammations NEC,Genitourinary tract disorders NEC,Renal,N
130,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
131,1,Sterile pyuria,Genitourinary tract infections and inflammations NEC,Genitourinary tract disorders NEC,Renal,N
132,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
133,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
133,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
133,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
134,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
135,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
135,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
135,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
135,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
135,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
137,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
138,1,Epstein-Barr virus antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
138,2,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
139,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
140,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
141,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
141,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
142,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
143,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
143,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
144,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
145,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
146,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
146,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
146,3,Lymphoma transformation,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
146,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
147,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
148,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
149,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
150,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
151,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
152,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
153,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
154,1,Acute leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
155,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
155,2,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
155,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
156,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
157,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
157,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
157,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
157,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
157,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
158,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
159,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
160,1,Acute leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
161,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
162,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
163,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
164,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
165,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
166,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
167,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
168,1,Acute leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
169,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
170,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
171,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
172,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
172,2,Idiosyncratic drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
174,1,Nail pigmentation,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
174,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
175,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
176,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
177,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
178,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
179,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
180,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
180,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
180,3,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
180,4,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
180,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
180,6,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
180,7,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
180,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
180,9,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
180,10,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
180,11,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
181,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
182,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
182,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
182,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
182,4,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
182,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
183,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
184,1,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
184,2,Lower respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
184,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
185,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
185,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
185,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
185,4,Recalled product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
186,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
186,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
186,3,Recalled product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
187,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
187,2,Gingival ulceration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
187,3,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
187,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
187,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
188,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
188,2,Leukaemia cutis,Leukaemias NEC,Leukaemias,Neopl,N
189,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
190,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
190,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
190,3,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
191,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
192,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
192,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
193,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
193,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
194,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
195,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
195,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
195,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
195,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
196,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
197,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
198,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
199,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
199,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
199,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
199,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
200,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
200,2,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
200,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
200,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
200,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
200,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
200,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
200,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
201,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
202,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
202,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
203,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
204,1,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
204,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
204,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
204,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
204,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
204,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
204,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
205,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
205,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
206,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
207,1,Genotoxicity,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
208,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
208,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
209,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
209,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
210,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
211,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
211,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
212,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
212,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
213,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
213,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
213,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
213,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
213,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
213,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
213,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
213,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
214,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
214,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
215,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
215,2,Acute myeloid leukaemia refractory,Leukaemias acute myeloid,Leukaemias,Neopl,N
215,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
215,4,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
215,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
215,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
216,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
216,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
216,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
216,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
216,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
216,6,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
216,7,Restrictive cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
216,8,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
216,9,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
216,10,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
217,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
217,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
218,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
219,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
220,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
220,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
221,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
222,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
223,1,Post lumbar puncture syndrome,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
224,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
